Abcam Plc’s (ABC) “Sell” Rating Reiterated at Panmure Gordon
Several other research analysts have also commented on ABC. Berenberg Bank assumed coverage on shares of Abcam Plc in a research note on Tuesday, June 27th. They set a buy rating and a GBX 1,100 ($14.21) price target on the stock. Peel Hunt restated a hold rating and set a GBX 750 ($9.69) price target on shares of Abcam Plc in a research note on Monday. Finally, Numis Securities Ltd restated an add rating and set a GBX 1,116 ($14.41) price target on shares of Abcam Plc in a research note on Thursday, July 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of Hold and an average price target of GBX 914 ($11.80).
Abcam Plc (LON:ABC) opened at 1031.00 on Monday. Abcam Plc has a 12-month low of GBX 759.50 and a 12-month high of GBX 1,113.00. The company’s 50 day moving average is GBX 1,055.16 and its 200 day moving average is GBX 955.02. The firm’s market cap is GBX 2.08 billion.
COPYRIGHT VIOLATION WARNING: “Abcam Plc’s (ABC) “Sell” Rating Reiterated at Panmure Gordon” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.dailypolitical.com/2017/09/15/abcam-plcs-abc-sell-rating-reiterated-at-panmure-gordon.html.
Abcam Plc Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.